The AppNL-G-F mouse model of Alzheimer's disease is refractory to regulatory T cell treatment
L. Yshii, L. Mascali, L. Kouser, P. Lemaitre, M. Marino, J. Dooley, O. Burton, J. Haughton, Z. Callaerts-Vegh, B. de Strooper, M. Holt, E. Pasciuto, A. Liston
This study shows that regulatory T cell therapy does not improve Alzheimer's disease progression in AppNL-G-F mice, suggesting limited therapeutic potential for this model.
bioRxiv · Mar 11, 2022 · PreprintImmunology